Market Cap (In GBp)
250.82 Million
Revenue (In GBp)
180.68 Million
Net Income (In GBp)
-33.13 Million
Avg. Volume
1.39 Million
- Currency
- GBp
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 24.55-50.256
- PE
- -
- EPS
- -
- Beta Value
- 0.642
- ISIN
- GB0031030819
- CUSIP
- G0179G102
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Nicholas John Sedgwick
- Employee Count
- -
- Website
- https://www.alliancepharmaceuticals.com
- Ipo Date
- 2001-11-22
- Details
- Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
More Stocks
-
SZLMYSwiss Life Holding AG
SZLMY
-
8137
-
FERROFerroamp AB (publ)
FERRO
-
ECNLFAquafil S.p.A.
ECNLF
-
ARTGFAirthings ASA
ARTGF
-
KCM
-
TRUE
-
688538